Ticagrelor or Prasugrel for Platelet Inhibition in Acute Coronary Syndrome Patients: The ISAR-REACT 5 Trial

J Am Coll Cardiol. 2020 Nov 24;76(21):2569-2571. doi: 10.1016/j.jacc.2020.09.586.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Coronary Syndrome / drug therapy*
  • Hemorrhage / chemically induced
  • Humans
  • Platelet Aggregation Inhibitors / pharmacology*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Prasugrel Hydrochloride / pharmacology*
  • Prasugrel Hydrochloride / therapeutic use
  • Ticagrelor / pharmacology*
  • Ticagrelor / therapeutic use

Substances

  • Platelet Aggregation Inhibitors
  • Prasugrel Hydrochloride
  • Ticagrelor

Associated data

  • ClinicalTrials.gov/NCT01944800